Bioresorbable biomaterials for next-generation dermal fillers and biostimulators
Evonik supports dermal filler manufacturers with high‑purity biomaterials designed to meet evolving requirements for patient safety, clinical performance, and regulatory compliance. The global medical aesthetics market continues to evolve beyond traditional volumizing approaches toward products designed to support skin quality, collagen formation and long-term aesthetic outcomes.
Our bioresorbable powders enable next‑generation dermal filler formulations that go beyond volume replacement to support aesthetic injectable treatments, including biostimulators, skin boosters, and regenerative approaches.
With decades of experience in medical polymers and regulated manufacturing, Evonik partners with customers from early material selection through clinical and commercial readiness.
Bioresorbable biomaterials for next-generation dermal fillers and biostimulators
Evonik supports dermal filler manufacturers with high‑purity biomaterials designed to meet evolving requirements for patient safety, clinical performance, and regulatory compliance. The global medical aesthetics market continues to evolve beyond traditional volumizing approaches toward products designed to support skin quality, collagen formation and long-term aesthetic outcomes.
Our bioresorbable powders enable next‑generation dermal filler formulations that go beyond volume replacement to support aesthetic injectable treatments, including biostimulators, skin boosters, and regenerative approaches.
With decades of experience in medical polymers and regulated manufacturing, Evonik partners with customers from early material selection through clinical and commercial readiness.
Advancing Aesthetic Injectable Technologies with Next Generation Bioresorbable Biomaterials
The medical aesthetics market continues to evolve toward products designed to support the body's natural regenerative processes. Today’s aesthetic biomaterials are expected to improve skin quality and deliver predictable, natural-looking results.
Evonik’s bioresorbable powders are ideally suited for next‑generation injectables in medical aesthetics, offering:
- High biocompatibility and safety profile
- Tunable degradation behavior
- Proven regulatory pathway
RESOMER® bioresorbable polymer powders
Evonik’s RESOMER® portfolio includes highly pure bioresorbable polymers such as Poly‑L‑lactic acid (PLLA), Polycaprolactone (PCL), and Polydioxanone (PDO) and multiple copolymers.
Available as ultra-fine powders and microgranules, these materials are well suited for aesthetic injectable applications. Their consistent quality and controlled physical characteristics support formulation development across a broad range of medical aesthetic products.
RESOMER®: differentiation through customization
A key part of Evonik’s offering for medical aesthetics is the RESOMER® Powder Platform. This includes two standard RESOMER® powder grades, and RESOMER® Powder Select, which can be tailored to specific application requirements.
Our proprietary solvent‑free RESOMER® micronization technology allows production of high‑purity bioresorbable powders without solvent residues.
Key advantages include:
- ISO 13485 and GMP manufacturing
- Clean‑room processing (ISO Class 8)
- Configurable particle characteristics to support formulation requirements
- Scalable production from lab to commercial volumes
The RESOMER® Powder Platform can be utilized for dermal filler applications, enabling control over material characteristics that support formulation development and product differentiation. This platform supports manufacturers to differentiate formulations while reducing development risk and accelerating time‑to‑market.
Biomaterials for advanced aesthetic injectable formulations
Whether developing a biostimulator, a skin booster, or other medical devices for aesthetic applications, Evonik’s biomaterials offer flexibility in degradation behavior, mechanical properties, and biological performance.
In addition to RESOMER®, Evonik offers VECOLLAN®, a recombinant collagen platform designed to provide the benefits of a highly consistent, non-animal-derived biomaterial. Produced through advanced biotechnology, VECOLLAN® combines purity, scalability and design flexibility, creating opportunities for differentiated medical aesthetic products. As interest in biomimetic and regenerative approaches continues to grow, VECOLLAN® provides developers with an innovative platform for exploring next-generation aesthetic applications.
Why partner with Evonik for medical aesthetic applications?
- Broad portfolio of bioresorbable and biocompatible materials
- Unique RESOMER® Powder Platform with customization capability
- Strong application, formulation, and regulatory support
- GMP and ISO 13485 manufacturing
- Decades of experience supporting global medical device manufacturers
Frequently asked questions (FAQ)
Evonik supplies high‑purity bioresorbable polymer powders and microgranules used by medical device manufacturers in the development of aesthetic injectable products. RESOMER® materials are supplied as raw materials and are not finished medical devices. Product formulation, regulatory approval, and commercialization remain the responsibility of the medical device manufacturer.
RESOMER® powders are incorporated into dermal filler formulations, where they are suspended or processed into injectable systems. After formulation into finished injectable products, bioresorbable polymers may contribute to application-specific performance characteristics depending on product design and intended clinical use.
Material characteristics, including particle size, can influence product performance attributes such as handling, degradation behavior, and biological interaction. Evonik's customizable powder platform allows manufacturers to tailor materials to specific development objectives.
Bioresorbable polymers are designed to degrade safely in the body over time. Their degradation profile and material properties make them suitable for a wide range of aesthetic injectable applications, depending on the intended product design.